INVESTORS

INVESTORS

Click here for Webcast
Q3 2018 Xtant Medical Holdings Inc Earnings Conference Call
11/14/18  4:30 PM EST

Corporate Profile

Xtant Medical Holdings, Inc. (NYSE MKT: XTNT) develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Xtant products serve the specialized needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders, and biologics to promote healing following cranial, and foot and ankle surgeries.

Stock Quote

Copyright West LLC. Minimum 15 minutes delayed.

Stock Chart

Recent News

Date Title  
Toggle Summary Xtant Medical Announces Third Quarter 2018 Financial Results
BELGRADE, MT , Nov. 14, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today reported financial and operating results for the third quarter ended September 30, 2018 .
Toggle Summary Xtant Medical to Issue Third Quarter 2018 Results on November 14, 2018
BELGRADE, MT , Nov. 12, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a leader in the development of regenerative medicine products and medical devices, today announced that it will release its financial results for the quarter and year to date ended September 30,
Toggle Summary Xtant Medical Announces Appointment of Interim CEO
BELGRADE, MT , Oct. 15, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the appointment of Michael Mainelli to serve as Interim Chief Executive
Toggle Summary Xtant Medical Announces Amendments to Credit Facility and Issuance of Warrants
BELGRADE, MT , Sept. 17, 2018 (GLOBE NEWSWIRE) -- Xtant Medical Holdings , Inc. (NYSE American: XTNT), a leader in the development and commercialization of regenerative medicine products and medical devices, today announced it has executed amendments to its credit facility reducing interest
Upcoming Events
There are currently no events scheduled.

Receive Email Alerts

Sign up to receive email alerts whenever Xtant Medical Holdings Inc posts new information to the site. Just enter your email address and click Submit.